TP53 and non-small cell lung carcinoma: The first study demonstrating that the restoration of p53 expression could suppress tumor growth was conducted in 1994 by Fujiwara et al. using a retroviral vector in an orthotropic human NSCLC model expressing a mutant P53 [179].